Grifols Deutschland GmbH

Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives. Since our founding in 1909, our ever-growing mastery of plasma, diagnostics and life sciences, backed by our ethical leadership and industry-leading quality and safety standards, have contributed to a healthier and more sustainable society.
Erfasste Deals
Ausgewählte TransaktionenIm Portfolio seitMarktLand
Grifols Biotest Holdings GmbH43GesundheitDeutschland
HAEMA AG85GesundheitDeutschland
Nach oben